Dexrazoxane Intravenous and Insulin Glargine (U-100) Vials
Determining the interaction of Dexrazoxane Intravenous and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Insulin Glargine (U-300) Pens
- Dexrazoxane Intravenous-Insulin glargine and lixisenatide
- Dexrazoxane Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Dexrazoxane Intravenous-Insulin glargine, recombinant Subcutaneous
- Dexrazoxane Intravenous-Insulin glulisine
- Dexrazoxane Intravenous-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Dextenza Insert
- Insulin Glargine (U-100) Vials-Dextenza intraocular
- Insulin Glargine (U-100) Vials-Dextran 40
- Insulin Glargine (U-100) Vials-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin Glargine (U-100) Vials-Dextran 75
- Insulin Glargine (U-100) Vials-Dextran high molecular weight